The burgeoning read more cannabis industry stands poised for explosive growth if the federal government undertakes the crucial step of rescheduling cannabis. Currently, its classification as a Schedule I drug creates massive barriers to development, limits banking and investment options, and perpetuates harmful policies. Rescheduling might unlock a